Ventas (NYSE:VTR – Get Free Report) had its target price lowered by analysts at Cantor Fitzgerald from $102.00 to $95.00 in a research note issued on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the real estate investment trust’s stock. Cantor Fitzgerald‘s price objective points to a potential upside of 17.58% from the stock’s previous close.
Several other equities research analysts also recently commented on the company. Wells Fargo & Company reduced their price objective on Ventas from $104.00 to $96.00 and set an “overweight” rating for the company in a report on Monday, October 19th. Weiss Ratings restated a “buy (b-)” rating on shares of Ventas in a research note on Monday, October 19th. Evercore set a $100.00 target price on shares of Ventas and gave the company an “outperform” rating in a research note on Monday, September 21st. Citigroup boosted their price objective on shares of Ventas from $100.00 to $110.00 and gave the company a “buy” rating in a report on Tuesday, August 4th. Finally, Jefferies Financial Group lowered their price objective on shares of Ventas from $102.00 to $95.00 in a research report on Monday, October 12th. Eighteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $98.59.
Check Out Our Latest Stock Report on VTR
Ventas Stock Performance
VTR stock opened at $80.79 on Thursday. The stock’s 50 day simple moving average is $87.46 and its 200 day simple moving average is $86.34. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86. Ventas has a 12-month low of $68.15 and a 12-month high of $101.60. The stock has a market capitalization of $41.44 billion, a PE ratio of 149.62, a price-to-earnings-growth ratio of 3.39 and a beta of 0.72.
Ventas (NYSE:VTR – Get Free Report) last posted its earnings results on Tuesday, October 27th. The real estate investment trust reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.98 by ($0.85). Ventas had a return on equity of 1.99% and a net margin of 4.08%. The business had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.77 billion. During the same period in the previous year, the business posted $0.88 EPS. The firm’s revenue for the quarter was up 23.0% on a year-over-year basis. As a group, research analysts forecast that Ventas will post 3.89 earnings per share for the current fiscal year.
Institutional Trading of Ventas
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Dynamic Wealth Strategies LLC purchased a new stake in Ventas during the first quarter valued at approximately $25,000. Silvant Capital Management LLC purchased a new position in shares of Ventas in the 2nd quarter worth approximately $28,000. Meeder Asset Management Inc. bought a new position in shares of Ventas during the 2nd quarter valued at approximately $30,000. Western Wealth Management LLC purchased a new stake in Ventas during the 1st quarter valued at $40,000. Finally, Ascentis Independent Advisors bought a new stake in Ventas in the first quarter worth $44,000. 94.18% of the stock is owned by hedge funds and other institutional investors.
Key Stories Impacting Ventas
Here are the key news stories impacting Ventas this week:
- Positive Sentiment: Ventas reported third-quarter normalized FFO of $0.99 per share, above the $0.98 consensus estimate and up from $0.88 a year earlier. Revenue increased 23% year over year to $1.83 billion, exceeding the $1.77 billion estimate. Ventas Q3 FFO and Revenues Top Estimates
- Positive Sentiment: Growth was led by the company’s senior housing operating portfolio, including higher occupancy, strong organic growth and gains in same-store net operating income. Management raised its full-year 2026 normalized FFO outlook to $3.87-$3.90 per share. Ventas Q3 FFO and Revenues Beat Estimates on Strong SHOP Growth
- Positive Sentiment: Ventas said its SHOP investment program has reached approximately $5.2 billion, highlighting continued expansion in senior housing and a potentially larger contribution from operating assets as occupancy improves. Ventas outlines 2026 normalized FFO outlook
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust focused on healthcare and senior housing properties. The company owns, manages and develops a diversified portfolio of healthcare-related real estate, including senior living communities, medical office buildings, life science and innovation centers, and other properties serving healthcare providers and institutions.
Ventas generally leases its properties to healthcare operators, physicians, health systems, universities and research organizations.
Further Reading
- Five stocks we like better than Ventas
- Garmin Raises Its Profit Outlook—Can the Stock Reach New Highs?
- Why Rising Rates Could Break the Bull Market Before AI Spending Can Save It
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
